CLINICAL EVIDENCE

The Science Behind Pelvic Floor Rehabilitation.

Understanding the clinical landscape is essential for practices evaluating pelvic health technologies. This page presents verified U.S. health statistics and published research on pelvic floor magnetic stimulation — the technology category underlying Emcora's product portfolio.

Pelvic Health — At a Glance

25M+Adults with UI in the U.S.
1 in 3Women affected over a lifetime
~15%Of men experience UI
>50%Of care facility residents

Sources: NIH, Johns Hopkins Medicine, NHANES 2021–2023, National Association for Continence. UI affects both women and men.

PUBLIC HEALTH DATA

Pelvic Health by the Numbers

These are publicly available U.S. health statistics about the condition — not product performance claims. They illustrate the scale of patient need that pelvic floor rehabilitation technologies are designed to address.

25M+

Adults Affected

Adults in the U.S. experience urinary incontinence

Source: Johns Hopkins Medicine

1 in 3

Women Over 18

Women experience UI at some point in their lives

Source: National Association for Continence

63%

Women Aged 20+

Of U.S. women aged 20+ report urinary incontinence symptoms

Source: NHANES 2021–2023

~15%

Men Affected

Of men experience urinary incontinence, including post-prostate surgery

Source: NIH / Aeroflow Urology

>50%

Care Facility Residents

Of nursing facility residents are affected by urinary incontinence

Source: NIH / Grand View Research

PUBLISHED RESEARCH

Research on Pelvic Floor Magnetic Stimulation Technology

The following summaries reference published peer-reviewed research on pelvic floor magnetic stimulation as a technology category — the same technology platform underlying products in Emcora's portfolio. These studies are presented for clinical education purposes.

Important: The research summaries below reference published studies on pelvic floor magnetic stimulation technology as a general category. They are presented for educational purposes and do not constitute specific clinical claims about MagBelle®, Pelcora, or any individual Emcora Medical product. Individual product outcomes may vary. Refer to the current Instructions for Use and applicable regulatory documentation for product-specific information.

INCONTINENCEWOMEN'S HEALTH

Significant
Reduction in leakage

Extracorporeal Magnetic Innervation for Stress Urinary Incontinence

Published research on Extracorporeal Magnetic Innervation (ExMI) has demonstrated statistically significant reductions in stress urinary incontinence episodes in women. Multiple peer-reviewed studies support the use of functional magnetic stimulation as a non-invasive rehabilitation approach.

Clinical ResearchPeer-reviewed urology literature on ExMI technology
MEN'S HEALTHREHABILITATION

Studied
Post-prostatectomy care

Magnetic Stimulation for Male Urinary Incontinence

Pelvic floor magnetic stimulation has been studied in male patients experiencing urinary incontinence following prostate procedures. Research has explored non-invasive electromagnetic approaches as a component of post-surgical rehabilitation planning.

Clinical ResearchPublished urology and rehabilitation literature
REHABILITATIONPELVIC FLOOR

Evidence
Based training support

Biofeedback-Assisted Pelvic Floor Muscle Training

Systematic review evidence, including reviews published in the Cochrane Database, supports biofeedback-assisted pelvic floor muscle training as an effective approach for improving pelvic floor muscle strength, coordination, and reducing incontinence severity.

Systematic ReviewCochrane Database of Systematic Reviews
QUALITY OF LIFEINCONTINENCE

Improved
Quality of life scores

Quality of Life Outcomes in Pelvic Floor Rehabilitation

Clinical literature consistently demonstrates that successful pelvic floor rehabilitation is associated with meaningful improvements in patient-reported quality of life measures. Reduced incontinence episodes correlate with improved social, psychological, and functional well-being.

Published Clinical LiteratureMultiple peer-reviewed journals on pelvic rehabilitation
DEVICE-SPECIFIC CLINICAL DATA

MagBelle® & Pelcora
Product Documentation

Device-specific clinical trial data, manufacturer documentation, and product-level regulatory information for MagBelle® and Pelcora will be made available on this page as it is provided by the manufacturer.

Healthcare providers seeking product documentation, Instructions for Use, or clinical reference materials are invited to contact our team directly.

Available Documentation
MagBelle® AF180 — FDA 510(k) Clearance K230767Available
MagBelle® Product Specifications & IFUOn Request
Pelcora — Clinical Platform DocumentationOn Request
Device-Specific Clinical Trial DataComing Soon
FOR CLINICAL PRACTICES

Speak With Our Team About the Technology.

Our team can provide verified product documentation, answer clinical questions, and help your practice evaluate whether MagBelle® or Pelcora is a fit for your patient population and practice environment.

Sales & Clinical Inquiries(615) 542-9941